CARB-X carb-x.org

CARB-X, aka The Combating Antibiotic Resistant Bacteria Biopharmaceutical Accelerator, is a public-private partnership devoted to antibacterial preclinical R&D. Funded by BARDA and Wellcome Trust, with in-kind support from NIAID, CARB-X will spend $450 million from 2017-2021 to support innovative products moving towards human clinical trials. CARB-X focuses on high priority drug-resistant bacteria, especially Gram-negatives. CARB-X is a charitable global public-private partnership led by Boston ...Show all

CARB-X, aka The Combating Antibiotic Resistant Bacteria Biopharmaceutical Accelerator, is a public-private partnership devoted to antibacterial preclinical R&D. Funded by BARDA and Wellcome Trust, with in-kind support from NIAID, CARB-X will spend $4...Show all

See All Exits Recent Exits

Phone:

Fax:

765 Commonwealth Ave
Suite 1201
 Boston, 02215
 Massachusetts, United States

CARB-X - Investments & Acquisitions

Show Real Data CARB-X Investments
See all Recent Investments
Date Company Round Amount Co-investors
2020-01-14TAXIS PharmaceuticalsGrant$3.2M
2020-01-13Trellis BioscienceGrant - II$3.2M
2020-01-08Centauri TherapeuticsUnattributed - III$1.4M
2020-01-02AntabioGrant - VIII$4.4M
2019-12-05Vedanta BiosciencesGrant - III$5.8M
See all 5 investments